Early dyskinesia--vulnerability.

Relative vulnerability to dyskinesia in terms of exposure to antipsychotic drugs prior to onset of dyskinesia was studied in a sample of 100 psychiatric patients with dyskinesia onset generally within a year or less of the point of study entry. Unipolar and bipolar patients were more vulnerable to dyskinesia than other diagnostic groups. In the total sample, lithium exposure did not appear to delay development of dyskinesia. Longer exposure to antiparkinson drugs was associated with delayed onset of dyskinesia. Past exposure to electroconvulsive therapy was related to decreased vulnerability to dyskinesia.
AuthorsJ O Cole, G Gardos, L A Boling, D Marby, D Haskell, P Moore
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 107 Issue 4 Pg. 503-10 ( 1992) ISSN: 0033-3158 [Print] GERMANY
PMID1603892 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Lithium
  • Adult
  • Bipolar Disorder (complications)
  • Depressive Disorder (complications)
  • Dyskinesia, Drug-Induced (etiology)
  • Electroconvulsive Therapy
  • Female
  • Humans
  • Lithium (therapeutic use)
  • Male
  • Psychiatric Status Rating Scales
  • Psychotic Disorders (complications, psychology)
  • Schizophrenia (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: